HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acquired activated protein C resistance associated with anti-protein S antibody as a strong risk factor for DVT in non-SLE patients.

Abstract
Anti-phospholipid (aPL) antibodies (Abs) are well known to be associated with thromboembolic events in patients with systemic lupus erythematosus (SLE). However, the clinical relevance of a PL Abs in patients without SLE (non-SLE) who have venous thromboembolism remains unclear. We evaluated 143 non-SLE patients with a first episode of clinically suspected deep vein thrombosis (DVT) by using objective tests for diagnosing DVT and laboratory tests including the activated protein C resistance (APC-R) test, the factor V Leiden test, and various aPL Abs. The prevalence of acquired APC-R, in which case there was no factor V Leiden mutation, was significantly higher in patients with DVT (15/58 cases, 25.9%, p < 0.0001) than in those without DVT (3/80 cases, 3.7%), and confirmed that acquired APC-R was a strong risk factor for DVT (odds ratio [OR], 8.95; 95% confidence intervals [CI], 2.45-32.7; p < 0.001). Multivariate logistic analysis revealed that the presence of LA, aCL, anti-beta2-glycoprotein I, anti-prothrombin and anti-protein C Abs was not reliable as a risk factor for DVT in non-SLE patients, and that the presence of anti-protein S Abs was the most significant risk factor for DVT (OR, 5.88; 95% CI, 1.96-17.7; p < 0.002). Furthermore, the presence of anti-protein S Abs was strongly associated with acquired APC-R (OR, 57.8; 95% CI, 8.53-391; p < 0.0001). These results suggest that acquired APC-R may reflect functional interference by anti-protein S Abs of the protein C pathway, which action may represent an important mechanism for the development DVT in non-SLE patients.
AuthorsJunzo Nojima, Hirohiko Kuratsune, Etsuji Suehisa, Tomio Kawasaki, Takashi Machii, Teruo Kitani, Yoshinori Iwatani, Yuzuru Kanakura
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 88 Issue 5 Pg. 716-22 (Nov 2002) ISSN: 0340-6245 [Print] Germany
PMID12428083 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antiphospholipid
  • Autoantibodies
  • Glycoproteins
  • Protein C
  • Protein S
  • beta 2-Glycoprotein I
  • factor V Leiden
  • Factor V
  • Prothrombin
Topics
  • Activated Protein C Resistance (complications, diagnosis)
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Antiphospholipid (analysis)
  • Autoantibodies (blood, physiology)
  • Factor V (analysis)
  • Female
  • Glycoproteins (immunology)
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Protein C (immunology)
  • Protein S (immunology)
  • Prothrombin (immunology)
  • Risk Factors
  • Venous Thrombosis (etiology, genetics, immunology)
  • beta 2-Glycoprotein I

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: